{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:55Z","timestamp":1792147795913,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objective:<\/jats:title>\n                    <jats:p>Hypoxia is a critical component of the tumor microenvironment\ncontributing to metabolic reprogramming and drug resistance. Subsequently, elucidating the molecular\nmechanisms involved in hypoxia regulation in tumor cell models is essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study used CRISPR\/Cas9 to knock out hepatocyte nuclear factor 4-alpha (HNF4-\u03b1)\nand hypoxia-inducible factor 1-alpha (HIF1-\u03b1) in HEPG2 cells. This study then assessed the effects\nof both knockouts (KO) on proliferation, migration, drug sensitivity, mitochondrial membrane stability,\nand gene expression in HEPG2 cells under both hypoxic and normoxic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our data demonstrate that HIF1-\u03b1 KO, but not HNF4-\u03b1 KO, sensitizes HEPG2 cells to doxorubicin\nunder hypoxic conditions. Additionally, the KO of both HIF1-\u03b1 and HNF4-\u03b1 enhances cell\nmigration, irrespective of oxygen levels. Importantly, both HIF1-\u03b1 and HNF4-\u03b1 are required for\ncellular response to hypoxia and the maintenance of mitochondrial function, as evidenced by the loss\nof mitochondrial membrane potential increase under hypoxia in KO cells. Microarray-based transcriptomic\nprofiling of HEPG2 cells revealed separation between HNF4-\u03b1 and HIF1-\u03b1 KO cells and\ncontrols under hypoxic versus normoxic conditions, with a markedly higher number of differentially\nexpressed genes in hypoxia (up to 5,595 genes; adjusted p &lt; 0.05, log2FC \u00b11.5). Both HNF4-\u03b1 and\nHIF1-\u03b1 contribute to hypoxia-responsive pathways, with impaired induction of key genes such as\nVEGFA and AK4 in KO cells, while GSEA indicated minimal effects of HNF4-\u03b1 loss under hypoxia\nbut pronounced metabolic pathway disruption in HIF1-\u03b1 KO cells. Moreover, key regulators of mitochondrial\nfunction and mitophagy, including FUNDC1, MIEF1, and MIEF2, were upregulated in\ncontrol hypoxic cells but not in KO cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings suggest that, in this single HEPG2 cell line model, HNF4-\u03b1 contributes\nto the regulation of cell migration and mitochondrial stability under hypoxic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Further investigation into the role of HNF4-\u03b1 in tumor biology is encouraged.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501512320261007111548","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:31Z","timestamp":1792146331000},"source":"Crossref","is-referenced-by-count":0,"title":["HNF4-\u03b1 Knockout Promotes HepG2 Cell Migration and Reduces Mitochondrial Membrane Potential under Hypoxic Conditions"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-1107","authenticated-orcid":true,"given":"Tareq","family":"Saleh","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133,Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-8764","authenticated-orcid":true,"given":"Mohammad A.","family":"Ismail","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"},{"name":"South Australian ImmunoGENomics CancerInstitute, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-984X","authenticated-orcid":true,"given":"Mirvat","family":"Surakhy","sequence":"additional","affiliation":[{"name":"Oxford Molecular PathologyInstitute, Sir William Dunn School of Pathology, University of Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fairouz","family":"Nairat","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1838-4025","authenticated-orcid":true,"given":"Mohammad H.","family":"Gharandouq","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dema","family":"Ali","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-8638","authenticated-orcid":true,"given":"Raghda","family":"Barham","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4371-9107","authenticated-orcid":true,"given":"Razan","family":"Aldiqs","sequence":"additional","affiliation":[{"name":"Department of Allied Sciences,Faculty of Arts and Sciences, Al-Ahliyya Amman University, Amman, 19111, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairallah","family":"Al-Abdallat","sequence":"additional","affiliation":[{"name":"Hemostasis and ThrombosisLaboratory, School of Medicine, the University of Jordan, Amman, Jordan"},{"name":"Department of Hematology and Oncology,Jordan University Hospital, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-3908","authenticated-orcid":true,"given":"Malek","family":"Zihlif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, The University ofJordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidaa A.","family":"Ababneh","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, the University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501512320261007111548","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259474\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501512320261007111548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:25:33Z","timestamp":1792146333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259474\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501512320261007111548","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}